Cargando…
The gut microbiome affects response of treatments in HER2‐negative advanced gastric cancer
BACKGROUND: Common treatments for metastatic/unresectable HER2‐negative gastric cancer include chemotherapy, immune checkpoint inhibitor monotherapy and chemotherapy plus immune checkpoint inhibitor. However, significant drug resistance exists regardless of the treatment regimen. METHODS: Patients w...
Autores principales: | Han, Zihan, Cheng, Siyuan, Dai, Die, Kou, Yan, Zhang, Xiaotian, Li, Fang, Yin, Xiaochen, Ji, Jingjing, Zhang, Zhikuan, Wang, Xi, Zhu, Ning, Zhang, Qi, Tan, Yan, Guo, Xiaohuan, Shen, Lin, Peng, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307992/ https://www.ncbi.nlm.nih.gov/pubmed/37381590 http://dx.doi.org/10.1002/ctm2.1312 |
Ejemplares similares
-
Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors
por: Zhang, Yifan, et al.
Publicado: (2023) -
Microbiome changes in the gastric mucosa and gastric juice in different histological stages of Helicobacter pylori-negative gastric cancers
por: Sun, Qing-Hua, et al.
Publicado: (2022) -
Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
por: Shi, Hong-Zhi, et al.
Publicado: (2017) -
Application of zebrafish in the study of the gut microbiome
por: Zhong, Xiaoting, et al.
Publicado: (2022) -
Captivity Influences the Gut Microbiome of Rhinopithecus roxellana
por: Wang, Xiaochen, et al.
Publicado: (2021)